News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Kristina Jankovic/X
Jan 20, 2025, 13:56

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“DC Approval!! US FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- Breast Cancer previously treated with endocrine and chemotherapy for unresectable, metastatic disease. ”

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Additional Information

cancer Kristina Jankovic OncoDaily Oncology
Special Coverage
Blog
Jun 26, 2025, 19:30
Getting Ready to Make the Most of Upcoming Events - EORTC
Blog
Jun 26, 2025, 19:22
Tobacco Taxation Gains Momentum in Kenya and Uganda Through Civil Society Mobilisation - UICC
Blog
Jun 26, 2025, 18:56
Late Breaking Abstract Submission Is Open - European Association of Neuro-Oncology
Blog
Jun 26, 2025, 18:44
Winan van Houdt: Pleased to Be Invited to the First Colombian Conference of Surgical Oncology
Positive
Jun 26, 2025, 18:34
Improving Life After Cancer for Survivors of Childhood and Adolescent Cancer - SIOP Europe
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski